Deborah J Wexler - Department of Medicine, Massachusetts General Hospital

基本信息

Career Trajectory

Bio

No content for now

Research Interests

Papers共 309 篇Author StatisticsCo-AuthorSimilar Experts

By YearBy Citation主题筛选期刊级别筛选合作者筛选合作机构筛选

Comparative Effectiveness of Individual Sodium-Glucose Cotransporter 2 Inhibitors

Hojin Shin,Julie M. Paik,Brendan M. Everett,Elyse Dicesare,Caroline Alix,Robert J. Glynn,Deborah J. Wexler,Elisabetta Patorno

JAMA INTERNAL MEDICINE (2025)

Cited0Views0WOSBibtex

Type 2 Diabetes Disease and Management Patterns Across a Large, Diverse Healthcare System: Issues and Opportunities for Guideline-Directed Therapies

Alexander J. Blood,Lee-Shing Chang,Caitlin Colling,Gretchen Stern,Daniel Gabovitch,David Zelle,Emily Zacherle,Joshua Noone,Carey Robar,Samuel J. Aronson,Thomas A. Gaziano,Lina S. Matta,Jorge Plutzky,Christopher P. Cannon,Deborah J. Wexler,Benjamin M. Scirica

American Heart Journal (2025)

Cited0Views0WOSBibtex

Association of Hospitalizations with Randomized Glycemia-Lowering Treatment in GRADE

Daniel S Hsia,Naji Younes,Alokananda Ghosh, Erin J Kazemi,Heidi Krause-Steinrauf,John B Buse, Chelsea Baker, Janet Brown-Friday, Elsa Diaz, Jamie Diner, Erik J Groessl, Elizabeth A Legowski, Cary N Mariash, Andrea H Waltje,Deborah J Wexler,Catherine L Martin, GRADE Research Group

Diabetes careno. 7 (2025): 1288-1294

Cited0Views0WOSBibtex

Empagliflozin Versus DPP4i or GLP-1RA for the Risk of Nephrolithiasis in Patients with Type 2 Diabetes: Research Letter from the EMPRISE Cohort Study

Helen Tesfaye,Julie M Paik,Heidi Zakoul,Niklas Schmedt,Deborah J Wexler,Elisabetta Patorno

Diabetes, obesity & metabolismno. 6 (2025): 3503-3508

Cited0Views0WOSBibtex

Overall Uptake and Racial, Ethnic, and Socioeconomic Disparities in the Use of Continuous Glucose Monitoring Devices among Insulin-Treated Older Adults with Type 2 Diabetes

Wajd Alkabbani, Sara J Cromer, Dae Hyun Kim,Julie M Paik,Katsiaryna Bykov,Medha Munshi,Deborah J Wexler,Elisabetta Patorno

Diabetes care (2025)

Cited0Views0WOSBibtex

Empagliflozin on the Risk of Retinopathy in Patients with Type 2 Diabetes-Results from the EMPRISE Study

Helen Tesfaye,Phyo Than T. Htoo,Julie M. Paik,Heidi Zakoul,Niklas Schmedt,Anouk Deruaz-Luyet,Lisette Koeneman,Deborah Wexler,Elisabetta Patorno

JAMA ophthalmology（2025）

Cited0Views0WOSBibtex

Trends in Utilization of Glucose- and Weight-Lowering Medications after Tirzepatide Approval in the United States : A Population-Based Cohort Study

John W Ostrominski, Janinne Ortega-Montiel,Helen Tesfaye, Caroline Alix, Elyse DiCesare, Sara J Cromer,Deborah J Wexler,Julie M Paik,Elisabetta Patorno

Annals of internal medicineno. 5 (2025): 620-633

Cited0Views0WOSBibtex

Utilization Trends of Glucose-Lowering Medications among Adult Kidney Transplant Recipients with Type 2 Diabetes in the United States

Panupong Hansrivijit,Helen Tesfaye,Deborah J. Wexler,Reza Abdi,Elisabetta Patorno,Julie M. Paik

JOURNAL OF CLINICAL MEDICINEno. 2 (2025)

Cited0Views0WOSBibtex

Utilization Trends of Dual GIP/GLP-1 Receptor Agonist, Newer Glucose-Lowering Medications, and Anti-Obesity Medications among Patients with Chronic Kidney Disease with and Without Type 2 Diabetes

Panupong Hansrivijit, Janinne Ortega-Montiel,Deborah J Wexler,Elisabetta Patorno,Julie M Paik

Kidney medicineno. 6 (2025): 101013-101013

Cited0Views0WOSBibtex

Weight Gain Was Associated with Worsening Glycemia and Cardiovascular and Kidney Outcomes in Patients with Type 2 Diabetes Independent of Diabetes Medication in the GRADE Randomized Controlled Trial

Deborah J Wexler,W Timothy Garvey,Alokananda Ghosh, Erin J Kazemi,Heidi Krause-Steinrauf, Andrew J Ahmann, Janet Brown-Friday, Sabina Casula, Andrea L Cherrington,Tom A Elasy, Stephen P Fortmann, Jonathan A Krakoff,Sunder Mudaliar,Margaret Tiktin,Naji Younes, GRADE Study Research Group

Diabetes careno. 6 (2025): 935-944

Cited0Views0WOSBibtex

Author Statistics

Co-Author

Co-Institution

D-Core

合作者
学生
导师

No result temporarily, you can search similar Scholar with the same research interest

Data Disclaimer

The page data are from open Internet sources, cooperative publishers and automatic analysis results through AI technology. We do not make any commitments and guarantees for the validity, accuracy, correctness, reliability, completeness and timeliness of the page data. If you have any questions, please contact us by email: report@aminer.cn